Epstein – Barr viral load, interleukin-6 and interleukin-10 levels in post-transplant lymphoproliferative disease: A nested case – control study in a renal transplant cohort
- 1 April 2005
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 46 (4), 533-539
- https://doi.org/10.1080/10428190400027837
Abstract
The possible correlation among Epstein - Barr virus (EBV) load, interleukin-6 (IL-6) and interleukin-10 (IL-10) levels has become an attractive issue and can provide a useful tool for diagnosis and monitoring of patients at risk for post-transplant lymphoproliferative disease (PTLD) development. At the time of diagnosis of PTLD, 11 patients were prospectively enrolled and 55 nested controls were selected from a 1800 renal transplant cohort. Real-time polymerase chain reaction (PCR) was used to quantify EBV load in peripheral blood mononuclear cells (PBMC). Serum IL-6 and IL-10 levels were determined using an enzyme-linked immunosorbent assay ( ELISA). the median EBV load of PTLD cases was 17400 copies/10(6) PBMC, statistically different from controls ( P = 0.001). the median IL-6 level of PTLD cases was not different from controls (P=0.079). However, median IL-10 levels showed a significant difference in both groups ( P <= 0.001). the receiver-operating characteristic (ROC) curve analysis was applied to estimate the IL-10 cut-off value predictive of PTLD development. We found that 73.5 pg/ml has high sensitivity (1.00) and specificity (0.85). Also, Pearson's analysis showed a strong correlation between EBV load and serum IL-10 concentration ( P <= 0.001). This nested case - control study demonstrates that EBV load at diagnosis of PTLD correlates with IL-10 levels, and that monitoring of IL-10 can provide a less expensive and less time-consuming tool for PTLD diagnosis and close follow-up of patients at risk. Furthermore, we were able to de. ne a cut-off value of IL-10 mostly predictive of PTLD development in this cohort. Our data suggest that serial measurements prior to PTLD development must be carried out to validate our hypothesis.Universidade Federal de São Paulo, EPM, Hematol & Transfus Med Serv, São Paulo, BrazilLudwig Inst Canc Res, São Paulo Branch, São Paulo, BrazilUNIFESP, EPM, Univ Hosp São Paulo, Discipline Nephrol, São Paulo, BrazilHosp Rim & Hipertensao, São Paulo, BrazilFleury Virol Div, São Paulo, BrazilUniversidade Federal de São Paulo, EPM, Dept Pathol, São Paulo, BrazilUniversidade Federal de São Paulo, EPM, Hematol & Transfus Med Serv, São Paulo, BrazilUNIFESP, EPM, Univ Hosp São Paulo, Discipline Nephrol, São Paulo, BrazilUniversidade Federal de São Paulo, EPM, Dept Pathol, São Paulo, BrazilWeb of SciencKeywords
This publication has 20 references indexed in Scilit:
- Epstein–Barr virus (EBV) load and interleukin‐10 in EBV‐positive and EBV‐negative post‐transplant lymphoproliferative disordersBritish Journal of Haematology, 2003
- Real‐time reverse transcriptase–polymerase chain reaction (RT–PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green IImmunology & Cell Biology, 2001
- The role of EBV in post-transplant malignancies: a reviewJournal of Clinical Pathology, 2000
- EPSTEIN-BARR VIRUS-INDUCED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERSTransplantation, 1999
- INTERLEUKIN-10 AND POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER AFTER KIDNEY TRANSPLANTATION1Transplantation, 1999
- SERIAL MEASUREMENT OF EPSTEIN-BARR VIRAL LOAD IN PERIPHERAL BLOOD IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS DURING TREATMENT FOR POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE1Transplantation, 1998
- EPSTEIN-BARR VIRUS DNA IN PERIPHERAL BLOOD LEUKOCYTES OF PATIENTS WITH POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASETransplantation, 1995
- Interleukin-6 production in posttransplant lymphoproliferative disease.Journal of Clinical Investigation, 1993
- Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice.Journal of Clinical Investigation, 1991
- Interleukin-6: An OverviewAnnual Review of Immunology, 1990